Will leave town if you retaliate: Cleric warns Muslims after riot mongers kill his 16-yr-old son

Udupi, June 30: A girl who appeared for SSLC exams in three subjects tested positive for COVID-19 in Kundapur taluk of Udupi district today.

Sheshashayana Karinja, Deputy Director of Public Instruction (DDPI) said that the 15-year-old girl had a headache and her parents took her for testing and she had tested positive for COVID-19.

She will appear for the remaining three subjects during the supplementary exams in August.

The room where the girl appeared for the exam had been sanitised. But exams would not be held in that room. All precautions have been taken in that exam centre in Kundapur taluk, Mr. Karinja said.

The other 19 students will be allowed to write their exams as there was a distance of one metre between them and there was no contact between the students during the exams, Mr. Karinja added.

It is learned that a couple of months ago, a Mumbai returnee who recovered from COVID-19 had visited the girl’s house. However, it is not clear that she got an infection from the Mumbai returnee.

It could be recalled here that a student from Hejamadi in Udupi district who was preparing for the Science exam had tested positive two days back and she is currently being treated at a hospital.

Newsroom, May 22: Countless netizens including Indians have hailed the action taken by Jazan University of Kingdom of Saudi Arabia against a high-ranking Indian expatriate who had posted called Indian Muslims as radicals.  

Social media platforms such as Twitter and Facebook flooded with appreciation after the University announced on Twitter that the professor, who had posted objectionable messsages, had been fired. The university, however, did not disclose the name of the professor. 

On its Twitter account, Jazan University wrote, “Based on what was monitored by the university about the publication of a contracted faculty member for offensive posts and tweets, his registration has already been folded. #JazanUniversity affirms that it resolutely addresses any perverted or extremist ideas that affect the constants or violate the directions of good leadership.”

After the university’s announcement, many on Twitter posted screenshots of the communal tweets claiming that the professor is Neeraj Bedi and made it clear that the dismissed professor is an Indian.

Bedi has been working as full time Professor in Faculty of Public Health and Tropical Medicine in Jazan University for years.

In his Twitter account, which does not currently exist, he was praising PM Modi and spewing poison against Islam and holding Muslims responsible for the spread of Coronavirus. It is believed that the account was deleted after the protests became severe.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.